Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives

Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives

Cefiderocol is a new cephalosporin displaying against extensively resistant (XDR) Gram-negative bacteria. We report our experience with cefiderocol-based combination therapies as “rescue” treatments in immunocompromised or critically ill patients or in patients with post-surgical infections who had...

Full description

Bibliographic Details
Main Authors:	Davide Fiore Bavaro, Alessandra Belati, Lucia Diella, Monica Stufano, Federica Romanelli, Luca Scalone, Stefania Stolfa, Luigi Ronga, Leonarda Maurmo, Maria Dell’Aera, Adriana Mosca, Lidia Dalfino, Salvatore Grasso, Annalisa Saracino
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Antibiotics
Subjects:	cefiderocol multidrug resistant gram-negative bacteria novel antimicrobial strategies <i>Pseudomonas aeruginosa</i> <i>Acinetobacter baumannii</i> <i>Klebsiella pneumoniae</i>
Online Access:	https://www.mdpi.com/2079-6382/10/6/652

Similar Items

Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study
by: Alexandre Bleibtreu, et al.
Published: (2021-01-01)

Shifting Gears: The Future of Polymyxin Antibiotics
by: Justin R. Lenhard, et al.
Published: (2019-04-01)

Long-Term Surveillance of Antibiotic Prescriptions and the Prevalence of Antimicrobial Resistance in Non-Fermenting Gram-Negative Bacilli
by: Chia-Huei Chou, et al.
Published: (2020-03-01)

Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions
by: Loukas Kakoullis, et al.
Published: (2021-04-01)

Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii
by: Alessandra Oliva, et al.
Published: (2020-12-01)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
by: Matteo Bassetti, et al.
Published: (2020-09-01)

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data
by: Giacobbe DR, et al.
Published: (2020-12-01)

Gram-Negative Bacteria Holding Together in a Biofilm: The <i>Acinetobacter baumannii</i> Way
by: Arianna Pompilio, et al.
Published: (2021-06-01)

Antimicrobial and Antibiofilm Effects of Peptides from Venom of Social Wasp and Scorpion on Multidrug-Resistant <i>Acinetobacter baumannii</i>
by: Rogério Coutinho das Neves, et al.
Published: (2019-04-01)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020-04-01)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against <i>Acinetobacter baumannii</i>
by: Min Ji Hong, et al.
Published: (2021-05-01)

Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria
by: Emily M. Eichenberger, et al.
Published: (2019-04-01)

<i>Pimenta</i> Oil as A Potential Treatment for <i>Acinetobacter Baumannii</i> Wound Infection: In Vitro and In Vivo Bioassays in Relation to Its Chemical Composition
by: Maha M. Ismail, et al.
Published: (2020-10-01)

Identification and Functional Analysis of Temperate Siphoviridae Bacteriophages of <i>Acinetobacter baumannii</i>
by: Shimaa Badawy, et al.
Published: (2020-05-01)

Ts2631 Endolysin from the Extremophilic <i>Thermus scotoductus</i> Bacteriophage vB_Tsc2631 as an Antimicrobial Agent against Gram-Negative Multidrug-Resistant Bacteria
by: Magdalena Plotka, et al.
Published: (2019-07-01)

Diversity of Oxacillinases and Sequence Types in Carbapenem-Resistant <i>Acinetobacter baumannii</i> from Austria
by: Andrea J. Grisold, et al.
Published: (2021-02-01)

Time-Resolved Transcriptional Profiling of Epithelial Cells Infected by Intracellular <i>Acinetobacter baumannii</i>
by: Nuria Crua Asensio, et al.
Published: (2021-02-01)

Sequential Hypertonic-Hypotonic Treatment Enhances Efficacy of Antibiotic against <i>Acinetobacter baumannii</i> Biofilm Communities
by: Azeza Falghoush, et al.
Published: (2020-11-01)

Protein Aggregation is Associated with <i>Acinetobacter baumannii</i> Desiccation Tolerance
by: Xun Wang, et al.
Published: (2020-02-01)

Overexpression of the <i>adeB</i> Efflux Pump Gene in Tigecycline-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates and Its Inhibition by (+)Usnic Acid as an Adjuvant
by: Nagaraju Bankan, et al.
Published: (2021-08-01)

Experimental Parameters Influence the Observed Antimicrobial Response of Oak Wood (<i>Quercus petraea</i>)
by: Muhammad Tanveer Munir, et al.
Published: (2020-08-01)

Transcriptional Regulation of the Outer Membrane Protein A in <i>Acinetobacter baumannii</i>
by: Kyu-Wan Oh, et al.
Published: (2020-05-01)

Competence for Natural Transformation Is Common among Clinical Strains of Resistant <i>Acinetobacter</i> spp.
by: Sara Domingues, et al.
Published: (2019-01-01)

Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2021-01-01)

Prevalence of antibiotic-resistant <i>Acinetobacter baumannii</i> in a 1000-bed tertiary care hospital in Tehran, Iran
by: Rahbar Mohammad, et al.
Published: (2010-04-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Tsung-Ying Yang, et al.
Published: (2021-08-01)

<i>Acinetobacter baumannii</i> Infections in Times of COVID-19 Pandemic
by: Karyne Rangel, et al.
Published: (2021-08-01)

Variations in Biofilm Formation and Motility Displayed by Isolates of <i> Acinetobacter baumannii</i>
by: McQueary, Christin Nicole
Published: (2010)

Safety and Therapeutic Efficacy of Thymoquinone-Loaded Liposomes against Drug-Sensitive and Drug-Resistant <i>Acinetobacter baumannii</i>
by: Khaled S. Allemailem, et al.
Published: (2021-05-01)

<i>Acinetobacter baumannii</i> LOS Regulate the Expression of Inflammatory Cytokine Genes and Proteins in Human Mast Cells
by: Takane Kikuchi-Ueda, et al.
Published: (2021-03-01)

Gram-Negative Bacterial Lysins
by: Chandrabali Ghose, et al.
Published: (2020-02-01)

An Application of Imipenem Discs or <i>P. aeruginosa</i> ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria
by: Tomasz Bogiel, et al.
Published: (2021-07-01)

Glycomics Microarrays Reveal Differential In Situ Presentation of the Biofilm Polysaccharide Poly-<i>N</i>-acetylglucosamine on <i>Acinetobacter baumannii</i> and <i>Staphylococcus aureus</i> Cell Surfaces
by: Andrea Flannery, et al.
Published: (2020-04-01)

Advances in Bacteriophage Therapy against Relevant MultiDrug-Resistant Pathogens
by: Antonio Broncano-Lavado, et al.
Published: (2021-06-01)

Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?
by: Song Oh, et al.
Published: (2021-05-01)

Synergistic Effect of Combinations Containing EDTA and the Antimicrobial Peptide AA230, an Arenicin-3 Derivative, on Gram-Negative Bacteria
by: Anita Umerska, et al.
Published: (2018-10-01)

Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
by: Janet Y. Wu, et al.
Published: (2020-02-01)

Clinical Relevance of Antibiotic Susceptibility Profiles for Screening Gram-negative Microorganisms Resistant to Beta-Lactam Antibiotics
by: Francisco Montiel-Riquelme, et al.
Published: (2020-10-01)